Explained herein are pharmaceutical packaging systems which stop oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-delicate medicine, such methods which includes a syringe having an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with extremely very low permeability to oxygen a